Jubilant Pharmova receives ratings for proposed NCDs of Rs 1400 cr
(21 Oct 2026)

Back
Jubilant Pharmova announced that India Ratings and Research has assigned the credit rating IND AA+; Stable to the company's proposed non-convertible debentures of Rs 1400 crore.

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew